Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CDR2 |
| Upstream (Parents) |
|---|
| (<<) ATP2C2 → CDR2 |
| (<<) GDF15 → CDR2 |
| (<<) HYAL1 → CDR2 |
| (<<) IGFBP4 → CDR2 |
| (<<) MAPK3 → CDR2 |
| (<<) MAPKAPK5 → CDR2 |
| (<<) MT1P2 → CDR2 |
| (<<) NNMT → CDR2 |
| (<<) NUDT6 → CDR2 |
| (<<) PAK1 → CDR2 |
| (<<) RBKS → CDR2 |
| (<<) ST3GAL1 → CDR2 |
| (<<) ST3GAL6 → CDR2 |
| (<<) TMC7 → CDR2 |
| (<<) TSPAN3 → CDR2 |
| Downstream (Children) |
|---|
| CDR2 → ADCY9 (>>) |
| CDR2 → AREG (>>) |
| CDR2 → CALML5 (>>) |
| CDR2 → CSNK1E (>>) |
| CDR2 → EPHB3 (>>) |
| CDR2 → G0S2 (>>) |
| CDR2 → GLS (>>) |
| CDR2 → MKNK2 (>>) |
| CDR2 → PELO (>>) |
| CDR2 → PLD1 (>>) |
